What is Sales and Marketing Strategy of Jointown Pharmaceutical Group Company?

This primary channel accounted for approximately 82% of the company's 2024 revenue. It directly supplies over 240,000 retail pharmacies and 19,000 public hospitals across China, supported by 40 modern distribution centers that ensure a 98.7% on-time delivery rate.

The Good Pharmacist (好药师) branded retail chain has grown to over 12,500 stores as of Q2 2025, making it one of China's top three pharmacy chains by store count. This extensive retail footprint provides a critical direct-to-consumer touchpoint and complements its wholesale pharmaceutical supply chain.

As the fastest-growing segment, online sales surged 45% in 2024 to reach CNY 18.2 billion. The proprietary platform integrates B2B and B2C marketplaces, offering an omnichannel experience for both pharmacy partners managing inventory and consumers ordering products for delivery or pickup.

Exclusive distribution deals with major international manufacturers like Pfizer and Roche for specific product lines are crucial. These partnerships grant significant market share and reinforce the company's value proposition as an indispensable partner within the broader Marketing Strategy of Jointown Pharmaceutical Group.

The company's foundational message as the 'Architect of a Trusted Health Ecosystem' underscores its shift from a pure logistics player to an integrated health partner. This positions the company as a reliable and innovative solution provider, a key part of the broader Competitors Landscape of Jointown Pharmaceutical Group.

Clean blue and green tones across its Good Pharmacist stores and digital assets communicate professionalism and a focus on wellness. The brand's tone is authoritative yet approachable, establishing it as a knowledgeable partner in health for all its audiences.

The company's unique selling proposition is its seamless integration of a vast physical drug distribution network with advanced digital health solutions. This appeals to B2B clients with supply chain efficiency and to consumers with unmatched convenience.

This consistent pharmaceutical distribution strategy was validated in a 2024 Frost & Sullivan report, which ranked the company first in brand preference among hospital procurement managers. This demonstrates the effectiveness of its B2B pharmaceutical sales approach.

Launched in Q4 2024, this campaign targeted 35 major cities with a promise of rapid OTC medicine delivery. It utilized geo-fenced mobile ads and push notifications to drive traffic to Good Pharmacist stores and its app.

The initiative resulted in a 28% uplift in app downloads and a significant 17% increase in same-store sales during the promotional period, boosting its retail pharmacy strategy.

This 2023 B2B pharmaceutical sales campaign introduced free digital inventory tools integrated with the wholesale platform. It targeted hospital procurement departments to become an essential part of their operational infrastructure.

By the end of 2024, the program successfully onboarded over 8,000 medical institutions. It achieved a client retention rate of 99.2% and substantially increased the share of wallet from these key clients.